GTPγS and forskolin-stimulated adenylyl cyclase activity in post-mortem brain from depressed suicides and controls

Molecular Psychiatry

Volumn 1, Issue 6, 1996, Pages 470-477

  Lowther, S ^a   Crompton, M R ^a   Katona, C L E ^b   Norton, R W ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Adenylyl cyclase; Antidepressant drug; Depression; Post mortem human brain; Signal transduction; Suicide

Indexed keywords

ADENYLATE CYCLASE; ANTIDEPRESSANT AGENT; FORSKOLIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE);

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN; CADAVER; COMPARATIVE STUDY; DEPRESSION; DRUG EFFECT; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SUICIDE;

ADENYLATE CYCLASE; ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BRAIN; CADAVER; DEPRESSION; FEMALE; FORSKOLIN; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; SUICIDE;

EID: 0030325538     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hudson CJ, Young LT, Li PP, Warsh JJ. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 1993; 13: 270-293.
2. Vetulani J, Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 1975; 257: 495-496.
3. Charney DS, Menkes DB, Heninger GR. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch Gen Psychiatry 1981; 38: 1160-1180.
4. Avissar S, Schreiber G. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders. Biol Psychiatry 1992; 31: 435-459.
5. Sulser F, Vetulani J, Mobley PL. Mode of action of antidepressant drugs. Biochem Pharmacol 1978; 27: 257-261.
6. Mishra R, Janowsky A, Sulser F. Action of mianserin and zimelidine on the norepinephrine receptor-coupled adenylate cyclase system in brain. Neuropharmacol 1980; 19: 983-987.
7. Okada F, Tokumitsu Y, Ui M. Desensitisation of β-adrenergic receptor-coupled adenylate cyclase in cerebral cortex after in vivo treatment of rats with dosipramine. J Neurochem 1986; 47: 454-459.
8. Menkes DB, Rasenick MM, Wheeler MA, Bitensky MW. Guanosine triphosphate activation of brain adenylate cyclase: enhancement of long-term antidepressant treatment. Science 1983; 219: 65-67.
9. Newman ME, Solomon H, Lerer B. Electroconvulsive shock and cyclic AMP signal transduction: effects distal to the receptor. J Neurochem 1986; 46: 1667-1669.
10. s to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol Pharmacol 1989; 36: 803-808.
11. 0α subunits. Eur J Pharmacol 1991; 207: 355-359.
12. i-2, α-subunit mRNA levels in rat cortex. Eur J Pharmacol 1991; 206: 165-166.
13. Extein I, Tallman J, Smith CC, Goodwill FK. Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiatric Res 1979; 1: 191-197.
14. Pandey GN, Dysken MW, Garner DL, Davis JM. Beta-adrenergic receptor function in affective illness. Am J Psychiatry 1979; 136: 675-678.
15. Mann JJ, Brown RP, Halper JP, Sweenet JA, Kocsis JH, Stokes PE, Bilezikian JP. Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. New Eng J Med 1985; 313: 715-720.
16. Ebstein RP, Lerer B, Shapira B, Shemesh Z, Moscovich DG, Kindler S. Cyclic AMP second-messenger signal amplification in depression. Br J Psychiatry 1988; 152: 665-669.
17. Thilo JB, Burnet PWJ. The role of adenylate cyclase in neuropsychiatric disease. Psychopharmacol Bull 1992; 28: 477-500.
18. Elliott JM. Peripheral markers in affective disorders. In: Horton RW, Katona CLE (eds). Biological Aspects of Affective Disorders. Academic Press: London, 1991, pp 95-144.
19. Schreiber G, Avissar S, Danon A, Belmaker RH. Hyperfunctional G-proteins in mononuclear leukocytes of patients with mania. Biol Psychiatry 1991; 29: 273-280.
20. Cowburn RF, Garlind A, O'Neill C, Alafuzoff I, Winblad B, Fowler CJ. Characterization and regional distribution of adenylyl cyclase activity from human brain. Neurochem Int 1991; 18: 389-390.
21. Cowburn RF', O'Neill C, Ravid R, Alafuzoff I, Winblad B, Fowler CJ. Adenylyl cyclase activity in post-mortem human brain: evidence of altered G-protein mediation in Alzheimer's disease. J Neurochem 1992; 58: 1409-1419.
22. Young LT, Warsh JJ, Li PP, Siu KP, Becker L, Gilbert J, Hornykiewicz O, Kish SJ. Maturational and aging effects on guanine nucleotide binding protein immunoreactivity in human brain. Dev Brain Res 1991; 61: 243-248.
23. sα protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem 1993; 61: 890-898.
24. Cowburn RF, Marcusson JO, Eriksson A, Wiehager B, O'Neill C. Adenylyl cyclase activity and G-protein subunit levels in post-mortem frontal cortex of suicide victims. Brain Res 1994; 633: 297-304.
25. Beskow J, Gottfries CG, Roos BE, Winblad B. Determination of monoamine and monoamine metabolites in the human brain: post-mortem studies in a group of suicides and in a control group. Acta Psychiatr Scand 1976; 53: 7-20.
26. 2 receptor binding sites in depressed suicide victims. Brain Bes 1988; 443: 272-280.
27. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
28. Brown BL, Albano DM, Ekins RP, Sgherzi AM. A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphate. Biochem J 1971; 121: 561-562.
29. s α-subunit levels are elevated in bipolar affective disorder. Brain Res 1991; 553: 323-326.
30. Ohm TG, Bohl J, Lemmer B. Reduced basal and stimulated (isoprenaline, Gpp(NH)p, forskolin) adenylate cyclase activity in Alzheimer's disease correlated with histopathological changes. Brain Res 1991; 540: 229-236.
31. Halper JP, Mann JJ, Weksler ME, Bilezikian JP, Sweeney JA, Brown RP, Golbourne T. Beta adrenergic receptors and cyclic AMP levels in intact human lymphocytes: effects of age and gender. Life Sci 1984; 35: 855-863.
32. Araki T, Kato H, Fujiwara T, Itoyama Y. Age-related changes in bindings of second messengers in the rat brain. Brain Res 1995; 704: 227-232.
33. Altman DG. How large a sample? In: Gore SM, Altman DG (ed). Statistics in Practice. British Medical Association: London, 1982, pp 6-8.